Literature DB >> 16258500

Dual-color, break-apart fluorescence in situ hybridization for EWS gene rearrangement distinguishes clear cell sarcoma of soft tissue from malignant melanoma.

Rajiv M Patel1, Erinn Downs-Kelly, Sharon W Weiss, Andrew L Folpe, Raymond R Tubbs, Ralph J Tuthill, John R Goldblum, Marek Skacel.   

Abstract

Clear cell sarcoma of soft tissue (malignant melanoma of soft parts) is a soft tissue sarcoma with melanocytic differentiation that typically occurs in the tendons and aponeuroses of young adults. As demonstrated by cytogenetics and reverse-transcriptase polymerase chain reaction, between 70% and over 90% of clear cell sarcomas have a t(12;22) translocation, fusing the EWS and ATF1 genes on chromosomes 22q12 and 12q13, respectively. Identification of this translocation distinguishes clear cell sarcoma from histologic mimics, most importantly conventional malignant melanoma. We report our experience with a commercially available, dual-color, break-apart fluorescence in situ hybridization (FISH) probe, which allows detection of EWS (22q12) gene rearrangement in formalin-fixed, paraffin-embedded tissues. Histologically and immunophenotypically well-characterized cases of clear cell sarcoma (n = 10) and malignant melanoma (n = 32) were evaluated with a 22q12 dual-color, break-apart probe (Vysis, Downer's Grove, IL, USA), which spans the known common breakpoints in the EWS gene on chromosome 22 (introns 7-10). Signals from tumor cell nuclei were counted under a fluorescence microscope and the presence of red-green break-apart signals was recorded. Of the clear cell sarcoma cases, seven of 10 showed evidence of an EWS gene rearrangement with a mean of 81.6% positive cells per sample (range: 60-95%). All cases of malignant melanoma (n = 32) showed virtually absent break-apart signals in the EWS gene (less than 4% cells per case). FISH detects EWS gene rearrangement in a substantial proportion of clear cell sarcomas, with excellent specificity. Importantly, EWS FISH is negative in malignant melanoma, a clinically dissimilar tumor, which may closely mimic clear cell sarcoma histologically and immunohistochemically. As the studied probe can be utilized in routinely processed tissue, FISH provides an excellent alternative to reverse-transcriptase polymerase chain reaction in cases where fresh tissue is unavailable.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16258500     DOI: 10.1038/modpathol.3800503

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  21 in total

1.  Clear cell sarcoma of the penis: a case report.

Authors:  Timothy Ito; Jonathan Melamed; Mary Ann Perle; Joseph Alukal
Journal:  Am J Clin Exp Urol       Date:  2015-04-25

Review 2.  Clear cell sarcoma of the pancreas: a case report and review of literature.

Authors:  Jie Huang; Rong-Kui Luo; Min Du; Hai-Ying Zeng; Ling-Li Chen; Yuan Ji
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

3.  Renal cell carcinomas with t(6;11)(p21;q12) presenting with tubulocystic renal cell carcinoma-like features.

Authors:  Qiu Rao; Xiu-Mei Zhang; Pin Tu; Qiu-Yuan Xia; Qin Shen; Xiao-Jun Zhou; Qun-Li Shi
Journal:  Int J Clin Exp Pathol       Date:  2013-06-15

4.  Cutaneous clear cell sarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 12 cases emphasizing its distinction from dermal melanoma.

Authors:  Markus Hantschke; Thomas Mentzel; Arno Rütten; Gabriele Palmedo; Eduardo Calonje; Alexander J Lazar; Heinz Kutzner
Journal:  Am J Surg Pathol       Date:  2010-02       Impact factor: 6.394

Review 5.  Out of the darkness and into the light: bright field in situ hybridisation for delineation of ERBB2 (HER2) status in breast carcinoma.

Authors:  Aaron M Gruver; Ziad Peerwani; Raymond R Tubbs
Journal:  J Clin Pathol       Date:  2010-03       Impact factor: 3.411

6.  Advantage of FISH analysis using FKHR probes for an adjunct to diagnosis of rhabdomyosarcomas.

Authors:  Tadaki Matsumura; Takehiko Yamaguchi; Kunihiko Seki; Tadakazu Shimoda; Takuro Wada; Toshihiko Yamashita; Tadashi Hasegawa
Journal:  Virchows Arch       Date:  2008-03       Impact factor: 4.064

7.  Primary pulmonary clear cell sarcoma-the first two reported cases.

Authors:  Giap Hean Goh; Ming Teh; Tomas Vanecek; Cesar Moran; Fredrik Petersson
Journal:  Virchows Arch       Date:  2016-04-25       Impact factor: 4.064

8.  Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 52 cases.

Authors:  O Hocar; A Le Cesne; S Berissi; P Terrier; S Bonvalot; D Vanel; A Auperin; C Le Pechoux; B Bui; J M Coindre; C Robert
Journal:  Dermatol Res Pract       Date:  2012-05-30

9.  Clear cell sarcoma: a case mimicking primary cutaneous malignant melanoma.

Authors:  M Rodríguez-Martín; M Sáez-Rodríguez; B Esquivel; R Sánchez Gonzáalez; A Noda Cabrera; A Martín Herrera
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

10.  Cutaneous clear cell sarcoma: a rare aggressive tumor with potential diagnostic challenge.

Authors:  Akshay Bali; Maitrayee Roy; Panduranga Chikkannaiah; Vijayalaxmi Dhorigol
Journal:  J Lab Physicians       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.